Vimarsana
Biggest News Aggregation in the World

Page 37 - Practice Guidelines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Practice Guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Practice Guidelines Today - Breaking & Trending Today

Diagnostic Advances Distinguish Actionable Drivers of Early Progression in ER+ Breast Cancer - Vimarsana News

Diagnostic Advances Distinguish Actionable Drivers of Early Progression in ER+ Breast Cancer

Ahmed Elkhanany, MD discusses unmet needs in patients with estrogen receptor–positive breast cancer who progress on frontline therapy, treatment considerations for these patients, and how FES PET imaging may benefit this population.

Probe Gold Increases Val-d'Or Mineral Resources to - Vimarsana News

Probe Gold Increases Val-d'Or Mineral Resources to

Highlights: Total Val-d’Or properties gold mineral resources currently stand at 3,793,900 ounces Measured and Indicated (“M&I”) and 1,418,700 ounces...

Probe Gold Increases Val-d'Or Mineral Resources to 3,793,900 Ounces of Gold Measured & Indicated and 1,418,700 Ounces Inferred, Doubles Amount of Measured and Indicated Mineral Resources - Vimarsana News

Probe Gold Increases Val-d'Or Mineral Resources to 3,793,900 Ounces of Gold Measured & Indicated and 1,418,700 Ounces Inferred, Doubles Amount of Measured and Indicated Mineral Resources

Highlights: Total Val-d'Or properties gold mineral resources currently stand at 3,793,900 ounces Measured and Indicated and 1,418,700 ounces Inferred along all trends and deposits, representing a 28% increase from the 2021 Mineral Resource Estimate.... - Veroeffentlicht am 19.07.2023

Novel Agents Highlight Changes in Myeloma Field - Vimarsana News

Novel Agents Highlight Changes in Myeloma Field

Leading investigators in the multiple myeloma field discuss the latest clinical trial findings, many of which were presented during the 2023 ASCO Annual Meeting.

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays - Vimarsana News

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.